Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Supriya Lifescience Ltd Q1FY24; 16% rise in Profits
Categories
Health Care
Strides Pharma Science Ltd Q1FY24; 1% fall in Revenue
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in
Shilpa Medicare Ltd Q1FY24; 50% fall in Profits
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of
Sequent Scientific Ltd Q1FY24; 2% fall in Revenue
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging
Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Suven Pharmaceuticals Ltd Q1FY25; 50% fall in Profits
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process
Wanbury Ltd.: Strategic Growth in High-Demand Therapeutic Areas and Expanding Global Reach
Company Overview Wanbury Ltd. is an Indian pharmaceutical company engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs) and formulations.
Sun Pharmaceuticals Industries Ltd Q1FY25; 43% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Narayana Hrudayalaya Ltd Q1FY25; 10% rise in Profits
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across
Global Health Ltd Q1FY25; 4% rise in Profits
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India.
Max Healthcare Institute Ltd Q1FY25; 2% fall in Profits
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and
Lupin Ltd Q1FY25; 78% rise in Profits
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,
Dr Lal Pathlabs Ltd Q1FY25; 29% rise in Profits
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Pfizer Ltd Q1FY25; 61% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Mankind Pharma Ltd Q1FY25; 25% rise in Profits
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer
Sanofi India Ltd Q1FY25; 16% fall in Profits
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for
Laurus Labs Ltd Q1FY25; 52% fall in Profits
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients
Syngene International Ltd Q1FY25; 18% fall in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Zydus Wellness Ltd Q4FY24; 3% rise in Profits
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution
Wockhardt Ltd Q4FY24; 3% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
Unichem Laboratories Ltd Q4FY24; 7% rise in Revenue
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd reported Revenues